Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Iridium Phosphine Oxazoline Complex. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111410604B details iridium-catalyzed asymmetric hydrogenation of enenoic acids, offering a direct route to chiral intermediates with high enantioselectivity and reduced processing steps.
Patent CN111410604A discloses iridium-phosphine oxazoline catalysis for high-purity chiral intermediates, enabling cost reduction in pharmaceutical manufacturing.